三祥新材(603663.SH):正在開展核級鉿材料的提取研究工作
格隆匯6月13日丨有投資者向三祥新材(603663.SH)提問,“鉿是半導體芯片的重要稀缺材料,只有美歐西方國家才有成熟的提取技術,為了限制我們國家的芯片發展,他們採用提價的方式,我們國家也把它作為一種重要的戰略資源,非常重視,東方鋯業僅有少量儲備,作為鋯業龍頭,請問貴公司有鋯鉿分離的相關技術儲備嗎?”
三祥新材回覆稱,公司正在開展核級鉿材料的提取研究工作,目前該技術開始在公司進行小試,另外,公司也將考慮適合的技術合作,以加速該項目的推進。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.